DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,104 filers reported holding DANAHER CORPORATION in Q4 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $11,284 | +65.2% | 45,176 | +53.0% | 0.25% | -19.9% |
Q4 2023 | $6,832 | -24.1% | 29,532 | -18.6% | 0.32% | -15.1% |
Q3 2023 | $9,005 | -15.4% | 36,297 | -18.1% | 0.37% | -11.4% |
Q2 2023 | $10,638 | -26.7% | 44,327 | -23.0% | 0.42% | -30.2% |
Q1 2023 | $14,505 | -5.1% | 57,550 | -0.1% | 0.60% | -10.1% |
Q4 2022 | $15,288 | -99.9% | 57,601 | -3.3% | 0.67% | +11.7% |
Q3 2022 | $15,390,000 | -17.7% | 59,584 | -19.2% | 0.60% | +8.5% |
Q2 2022 | $18,698,000 | -15.4% | 73,755 | -2.1% | 0.55% | +5.9% |
Q1 2022 | $22,107,000 | -1.9% | 75,364 | +10.0% | 0.52% | +13.0% |
Q4 2021 | $22,540,000 | +26.2% | 68,508 | +16.7% | 0.46% | +15.2% |
Q3 2021 | $17,865,000 | +3.6% | 58,680 | -8.7% | 0.40% | +20.1% |
Q2 2021 | $17,243,000 | +237.1% | 64,255 | +182.8% | 0.33% | +227.5% |
Q1 2021 | $5,115,000 | -55.5% | 22,725 | -56.1% | 0.10% | -57.1% |
Q4 2020 | $11,504,000 | -4.5% | 51,789 | -7.4% | 0.24% | -15.0% |
Q3 2020 | $12,047,000 | +17.1% | 55,946 | -3.9% | 0.28% | +8.9% |
Q2 2020 | $10,290,000 | -3.6% | 58,190 | -24.5% | 0.26% | -13.5% |
Q1 2020 | $10,671,000 | -16.3% | 77,094 | -7.2% | 0.30% | +8.0% |
Q4 2019 | $12,754,000 | -3.5% | 83,099 | -9.2% | 0.28% | -8.9% |
Q3 2019 | $13,219,000 | -8.6% | 91,523 | -9.6% | 0.30% | -5.6% |
Q2 2019 | $14,465,000 | -2.0% | 101,210 | -9.5% | 0.32% | -1.8% |
Q1 2019 | $14,764,000 | +31.6% | 111,835 | +2.8% | 0.33% | +16.4% |
Q4 2018 | $11,215,000 | -14.6% | 108,758 | -10.1% | 0.28% | +8.1% |
Q3 2018 | $13,140,000 | +5.2% | 120,925 | -4.4% | 0.26% | +1.2% |
Q2 2018 | $12,485,000 | +0.7% | 126,516 | -0.1% | 0.26% | +3.6% |
Q1 2018 | $12,396,000 | +5.5% | 126,602 | 0.0% | 0.25% | +6.0% |
Q4 2017 | $11,751,000 | +21.6% | 126,602 | +12.4% | 0.23% | +8.4% |
Q3 2017 | $9,666,000 | -5.7% | 112,679 | -7.2% | 0.22% | -1.8% |
Q2 2017 | $10,248,000 | -17.5% | 121,437 | -16.4% | 0.22% | -19.8% |
Q1 2017 | $12,426,000 | +17.5% | 145,283 | +6.9% | 0.27% | +10.1% |
Q4 2016 | $10,576,000 | +46.5% | 135,869 | +47.6% | 0.25% | +65.3% |
Q3 2016 | $7,218,000 | -33.7% | 92,076 | -14.5% | 0.15% | -40.5% |
Q2 2016 | $10,882,000 | +30.0% | 107,744 | +22.1% | 0.25% | +26.0% |
Q1 2016 | $8,371,000 | +5.0% | 88,246 | +2.8% | 0.20% | +6.4% |
Q4 2015 | $7,973,000 | -4.5% | 85,837 | -21.9% | 0.19% | +42.4% |
Q3 2015 | $8,345,000 | -2.1% | 109,837 | +10.3% | 0.13% | -22.8% |
Q2 2015 | $8,524,000 | +10.5% | 99,592 | +9.6% | 0.17% | +27.6% |
Q1 2015 | $7,714,000 | -22.8% | 90,862 | -22.0% | 0.13% | -16.2% |
Q4 2014 | $9,990,000 | +19.7% | 116,557 | +6.1% | 0.16% | +23.1% |
Q3 2014 | $8,345,000 | -7.0% | 109,837 | -3.6% | 0.13% | -5.8% |
Q2 2014 | $8,970,000 | -3.9% | 113,937 | -8.5% | 0.14% | -11.0% |
Q1 2014 | $9,334,000 | -3.9% | 124,457 | -1.1% | 0.16% | -6.1% |
Q4 2013 | $9,713,000 | -22.6% | 125,822 | -30.5% | 0.16% | -28.6% |
Q3 2013 | $12,552,000 | +16.4% | 181,070 | +6.3% | 0.23% | +12.7% |
Q2 2013 | $10,779,000 | – | 170,277 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |